U.S. Markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.09
    -0.34 (-0.31%)
     
  • Gold

    1,806.40
    +4.90 (+0.27%)
     
  • Silver

    19.75
    +0.09 (+0.45%)
     
  • EUR/USD

    1.0455
    +0.0028 (+0.2718%)
     
  • 10-Yr Bond

    2.8890
    0.0000 (0.00%)
     
  • Vix

    26.70
    -2.01 (-7.00%)
     
  • GBP/USD

    1.2126
    +0.0023 (+0.1904%)
     
  • USD/JPY

    135.4500
    +0.2750 (+0.2034%)
     
  • BTC-USD

    19,435.27
    +341.40 (+1.79%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • FTSE 100

    7,241.58
    +72.93 (+1.02%)
     
  • Nikkei 225

    26,153.81
    +218.19 (+0.84%)
     

Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ST. PAUL, Minn., January 27, 2022--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at the SVB Leerink 2022 Global Healthcare Conference on February 18th. A webcast of the presentation will be made available here.

SVB Leerink 2022 Global Healthcare Conference
Friday, February 18, 2022
12:00 p.m. ET

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220127005014/en/

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
Vice President, Investor Relations
& Corporate Communications
(651) 202-4919
j.nielsen@csi360.com